A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

Name: A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis
License: Public Domain

Pfizer

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

chronic kidney disease (ckd)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 398224
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.